Literature DB >> 18004400

Hydrodynamic gene delivery to the pig liver via an isolated segment of the inferior vena cava.

J W Fabre1, A Grehan, M Whitehorne, G J Sawyer, X Dong, S Salehi, L Eckley, X Zhang, M Seddon, A M Shah, M Davenport, M Rela.   

Abstract

Hydrodynamic gene delivery is an attractive option for non-viral liver gene therapy, but requires evaluation of efficacy, safety and clinically applicable techniques in large animal models. We have evaluated retrograde delivery of DNA to the whole liver via the isolated segment of inferior vena cava (IVC) draining the hepatic veins. Pigs (18-20 kg weight) were given the pGL3 plasmid via two programmable syringe pumps in parallel. Volumes corresponding to 2% of body weight (360-400 ml) were delivered at 100 ml s(-1) via a Y connector. The IVC segment pressure, portal venous pressure, arterial pressure, electrocardiogram (ECG) and pulse were monitored. Concurrent studies were performed in rats for interspecies comparisons. The hydrodynamic procedure generated intrahepatic vascular pressures of 101-126 mm Hg, which is approximately 4 times higher than in rodents, but levels of gene delivery were approximately 200-fold lower. Suprahepatic IVC clamping caused a fall in arterial pressure, with the development of ECG signs of myocardial ischaemia, but these abnormalities resolved rapidly. The IVC segment approach is a clinically acceptable approach to liver gene therapy. However, it is less effective in pigs than in rodents, possibly because of larger liver size or a less compliant connective tissue framework.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18004400     DOI: 10.1038/sj.gt.3303079

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  39 in total

1.  Long-term expression of human coagulation factor VIII in a tolerant mouse model using the φC31 integrase system.

Authors:  Christopher L Chavez; Annahita Keravala; Jacqueline N Chu; Alfonso P Farruggio; Vanessa E Cuéllar; Jan Voorberg; Michele P Calos
Journal:  Hum Gene Ther       Date:  2012-01-26       Impact factor: 5.695

2.  Feasibility of bloodless liver resection using Lumagel, a reverse thermoplastic polymer, to produce temporary, targeted hepatic blood flow interruption.

Authors:  James J Pomposelli; Mohamed Akoad; Sebastian Flacke; James J Benn; Mauricio Solano; Aarti Kalra; Peter N Madras
Journal:  HPB (Oxford)       Date:  2011-11-21       Impact factor: 3.647

Review 3.  Physical methods of nucleic acid transfer: general concepts and applications.

Authors:  Julien Villemejane; Lluis M Mir
Journal:  Br J Pharmacol       Date:  2009-01-21       Impact factor: 8.739

Review 4.  Nonviral gene delivery: principle, limitations, and recent progress.

Authors:  Mohammed S Al-Dosari; Xiang Gao
Journal:  AAPS J       Date:  2009-10-16       Impact factor: 4.009

Review 5.  Efficacy and safety of Sleeping Beauty transposon-mediated gene transfer in preclinical animal studies.

Authors:  Perry B Hackett; Elena L Aronovich; David Hunter; Myra Urness; Jason B Bell; Steven J Kass; Laurence J N Cooper; Scott McIvor
Journal:  Curr Gene Ther       Date:  2011-10       Impact factor: 4.391

Review 6.  The Sleeping Beauty transposon system: a non-viral vector for gene therapy.

Authors:  Elena L Aronovich; R Scott McIvor; Perry B Hackett
Journal:  Hum Mol Genet       Date:  2011-04-01       Impact factor: 6.150

7.  Transgene Expression in Dogs After Liver-Directed Hydrodynamic Delivery of Sleeping Beauty Transposons Using Balloon Catheters.

Authors:  Kendra A Hyland; Elena L Aronovich; Erik R Olson; Jason B Bell; Myra Urness Rusten; Roland Gunther; David W Hunter; Perry B Hackett; R Scott McIvor
Journal:  Hum Gene Ther       Date:  2017-04-19       Impact factor: 5.695

8.  Human AAT gene transfer to pig liver improved by using a perfusion isolated organ endovascular procedure.

Authors:  Luis Sendra; Daniel Pérez; Antonio Miguel; María José Herrero; Inmaculada Noguera; Ana Díaz; Domingo Barettino; Luis Martí-Bonmatí; Salvador F Aliño
Journal:  Eur Radiol       Date:  2015-04-25       Impact factor: 5.315

9.  Impact of hydrodynamic injection and phiC31 integrase on tumor latency in a mouse model of MYC-induced hepatocellular carcinoma.

Authors:  Lauren E Woodard; Annahita Keravala; W Edward Jung; Orly L Wapinski; Qiwei Yang; Dean W Felsher; Michele P Calos
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

10.  Effect of nuclear localization and hydrodynamic delivery-induced cell division on phiC31 integrase activity.

Authors:  L E Woodard; R T Hillman; A Keravala; S Lee; M P Calos
Journal:  Gene Ther       Date:  2009-10-22       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.